Abstract
In this brief review we will discuss some recent trends in work on regulatory mechanisms involved in the selective expression of differentiated markers in human B-cell lines as well as the types of controls involved in the expression and function of Epstein-Barr virus (EBV) associated markers in human cells. A problem of special interest in this connection is the relation of the expression of EBV functions to the expression of “transformation”.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adams A (1979) The state of the virus genome in transformed cells and its relationship to host cell DNA. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin, p 155
Allan M, Harrison P (1980) Co-expression of differentiation markers in hybrids between Friend cells and lymphoid cells and the influence of cell shape. Cell 19:437
Baron D, Strominger JL (1978) Partial purification and properties of the Epstein-Barr virus — associated nuclear antigen. J Biol Chem 253:2875
Béchet JM, Fialkow RJ, Nilsson K, Klein G (1974) Immunoglobulin synthesis and glucose-6-phosphate dehydrogenase as cell markers in human lymphoblastoid cell lines. Exp Cell Res 89:275
Ber R, Klein G, Moar M, Povey S, Rosén A, Westman A, Yefenof E, Zeuthen J (1978) Somatic cell hybrids between human lymphoma lines. IV. Establishment and characterization of a P3HR-1/DAUDI hybrid. Int J Cancer 21:707
Bernard O, Hozumi N, Tonegawa S (1978) Sequences of mouse immunoglobulin light chain genes before and after somatic changes. Cell 15:1133
Clements GB, Klein G, Povey S (1975) Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA. Int J Cancer 16:125
Cohen MM, Sagi M, Ben-Zur Z, Schaap T, Voss R, Kohn G (1979) Ataxia telangiectasia: Chromosomal stability in continuous lymphoblastoid cell lines. Cytogenet Cell Genet 23:44
Collins SJ, Gallo RC, Gallagher RE (1977) Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270:347
Einhorn L, Steinitz M, Yefenof E, Ernberg I, Bakacs T, Klein G (1978) Epstein-Barr virus (EBV) receptors complement receptors, and EBV infectability of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies. Cell Immunol 35:43
Epstein MA, Achong BG (1979) Discovery and general biology of the virus. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Berlin, Springer, p 1
Ernberg I, Klein G (1979) EB virus-induced antigens. In: The Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin, p 39
Eskeland T, Klein E (1971) Isolation of 7S IgM and kappa chains from the surface membrane of tissue culture cells derived from a Burkitt lymphoma. J Immunol 107:1367
Fellous M, Kamoun M, Wiels J, Dausset J, Clements G, Zeuthen J, Klein G (1977) Induction of HLA expression in Daudi cells after cell fusion. Immunogenetics 5:423
Fialkow PJ, Klein G, Gartier SM, Clifford P (1970) Clonal origin for individual Burkitt tumors. Lancet I;384
Fialkow PJ, Klein E, Klein G, Clifford P, Singh S (1973) Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma. J Exp Med 138:89
Fresen KO, zur Hausen H (1976) Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains. Int J Cancer 17:161
Gergely L, Klein G, Ernberg I (1971) The action of DNA antagonists on Epstein-Barr virus (EBV)-associated early antigens (EA) in Burkitt lymphoma lines. Int J Cancer 7:293
Glaser R, Nonoyama M (1973) Epstein-Barr virus: Detection of the genome in somatic cell hybrids of Burkitt lymphoblastoid cells. Science 179:492
Glaser R, Rapp F (1972) Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells. J Virol 10:288
Glaser R, Ablashi DV, Nonoyama M, Henle W, Easton J (1977) Enhanced oncogenic behavior of human and mouse cells after cellular hybridization with Burkitt tumor cells. Proc Natl Acad Sci USA 74:2574
Goodfellow PN, Jones EA, van Heyningen V, Solomon E, Bobrow M, Miggiano V, Bodmer WP (1975) The β2-microglobulin gene is on chromosome 15 and not in the HLA region. Nature 254:267
Graessmann A, Graessmann M, Guhl E, Mueller C (1978) Quantitative correlation between simian virus 40 T-antigen synthesis and late viral gene expression in permissive and non-permissive cells. J Cell Biol 77:R1
Graessmann A, Wolf H, Bornkamm GW (1980) Expression of Epstein-Barr virus genes in different cell types after microinjection of viral DNA. Proc Natl Acad Sci USA 77:433
Hellriegel KP, Diehl V, Krause PH, Meier S, Blankenstein M, Busche W (1977) The significance of chromosomal findings for the differentiation between lymphoma and lymphoblastoid cell lines. In: Thierfelder S, Rodt H, Thiel E (eds) Hematology and blood transfusion. Immunological diagnosis of leukemias and lymphomas. Springer, Berlin, p. 307
Henle G, Henle W (1979) The virus as the etiologic agent of infectious mononucleosis. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin, p 297
Jarvis JE, Ball G, Rickinson AB, Epstein MA (1974) Cytogenetic studies on human lymphoblastoid cell lines from Burkitt’s lymphoma and other sources. Int J Cancer 14:716
Jondal M, Klein G (1973) Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus (EBV) receptors on B lymphocytes. J Exp Med 138:1365
Jondal M, Klein G, Oldstone M, Bokish V, Yefenof E (1976), Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus (EBV) receptors on human lymphoid cells. Scand J Immunol 5:401
Klein G (1979) The relationship of the virus to nasopharyngeal carcinoma. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin, p 339
Klein E, Eskeland T, Inoue M, Strom R, Johansson B (1970) Surface immunoglobulin moieties on lymphoid cells. Exp Cell Res 62:133
Klein G, Wiener F, Zech L, zur Hausen H, Reedman B (1974) Segregation of the EBV-determined nuclear antigen (EBNA) in somatic cell hybrids derived from the fusion of a mouse fibroblast and a human Burkitt line. Int J Cancer 14:54
Klein G, Giovanella B, Westman A, Stehlin J, Mumford D (1975) An EBV-genome-negative cell line established from an American Burkitt lymphoma: Receptor characteristics, EBV infectability and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5:319
Klein G, Zeuthen J, Terasaki P, Billing R, Honig R, Jondal M, Westman A, Clements G (1976a) Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines. Int J Cancer 18:639
Klein G, Clements G, Zeuthen J, Westman A (1976b) Somatic cell hybrid between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle. Int J Cancer 17:71515
Klein G, Terasaki P, Billing R, Honig R, Jondal M, Rosén A, Zeuthen J, Clements G (1977a) Somatic cell hybrids between human lymphoma lines. III. Surface markers. Int J Cancer 19:66
Klein G, Clements G, Zeuthen J, Westman A (1977b) Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids. Cancer Lett 3:91
Klein G, Zeuthen J, Eriksson I, Terasaki P, Bernoco M, Rosén A, Masucci G, Povey S, Ber R (1980) Hybridization of a myeloid leukemia — derived human cell line (K562) with a human Burkitt’s lymphoma line (P3HR-1). J Natl Cancer Inst 64:725
Klein G, Luka J, Zeuthen J (1980) Epstein-Barr virus (EBV)-induced transformation and the role of the nuclear antigen (EBNA). Cold Spring Harbor Symp Quant Biol 44:253
Koskimies S (1980) A human lymphoblastoid cell line producing specific antibody against Rh-D antigen. Scand J Immunol 11:73
Kozbor D, Steinitz M, Klein G, Koskimies S, Mäkelä O (1979) Establishment of anti-TNP antibody producing human lymphoid lines by preselection for hapten binding followed by EBV transformation. Scand J Immunol 10:187
Lenoir G, Bertheion MC, Faure MC, de Thé G (1976) Characterization of Epstein-Barr virus antigens. I. Biochemical analysis of the complement-fixing soluble antigen and relationship with Epstein-Barr virus — associated nuclear antigen. J Virol 17:672
Luka J, Siegert W, Klein G (1977) Solubilization of the Epstein-Barr virus determined nuclear antigen and its characterization as a DNA-binding protein. J Virol 22:1
Luka J, Lindahl T, Klein G (1978) Purification of the Epstein-Barr virus determined nuclear antigen from Epstein-Barr virus transformed human lymphoid cell lines. J Virol 27:604
Luka J, Jörnvall H, Klein G (to be published) Purification and biochemical characterization of the Epstein-Barr virus (EBV) determined nuclear antigen (EBNA) and and an associated protein with a 53K subunit.
Manolov G, Manolova Y (1972) marker band in one chromosome 14 from Burkitt lymphomas. Nature 237:33
Matsuoka Y, Takahashi M, Yagi Y, Moore GE, Pressman (1968) Synthesis and secretion of Immunoglobulins by established cell lines of human hematopoietic origin. J Immunol 101:1111
McCaw KB, Hecht F, Harnden DG, Teplitz RJ (1975) Somatic rearrangement of chromosome 14 in human lymphocytes. Proc Natl Acad Sci USA 72:2071
McConnell I, Klein G, Lint TF, Lachmann PJ (1978) Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells. Eur J. Immunol 8:453
McCormick F, Harlow E (1980) Association of a murine 53,000-daltonphosphoprotein with simian virus 40 large-T antigen in transformed cells. J Virol 34:213
Menezes J, Leibold W, Klein G, Clements G (1975) Establishment of an Epstein-Barr virus (EBV)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt’s lymphoma. Biomedicine 22:276
Moar MH, Ber R, Klein G, Westman A, Eriksson I (1978) Somatic cell hybrids between human lymphoma lines. V. IUdR inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines. Int J Cancer 22:669
Montagnier L, Gruest J (1979) Cell-density-dependence for growth in agarose of two human lymphoma lines and its decrease after Epstein-Barr virus conversion. Int J Cancer 23:71
Nilsson K (1978) Established human lymphoid cell lines as models for B-lymphocyte differentiation. In: Serrou B, Rosenfeld C (eds) Human lymphocyte differentiation: Its application to cancer. North-Holland, Amsterdam, p 307
Nilsson K, Pontén J (1975) Classification and biological nature of established human hematopoietic cell lines. Int J Cancer 15:321
Nilsson K, Giovanella BC, Stehlin JS, Klein G (1977) Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Int J Cancer 19:337
Nyormoi O, Klein G, Adams A, Dombos L (1973) Sensitivity to EBV superinfection and IUdR inducibility of hybrid cells formed between a sensitive and a relatively resistant Burkitt lymphoma cell line. Int J Cancer 12:396
Oliver N, Francke U, Pellegrino MA (1978) Regional assignment of genes for mannose phosphate isomerase, pyruvate kinase 3, and β2-microglobulin expression on human chromosome 15 by hybridization of cells from a t(15;22) (q14;q13.3) translocation carrier. Cytogenet Cell Genet 22:506
Plesner T (1978) Lymphocyte associated β2-microglobulin studied by crossed radioimmunoelectrophoresis. Scand J Immunol 8:363
Pope JH (1979) Transformation by the virus in vitro. In: Epstein MA, Achong BG (eds) The Epstein-Barr virus. Springer, Berlin p 205
Povey S, Jeremiah S, Arthur E, Ber R, Fialkow PJ, Gardiner E, Goodfellow PN, Karande A, Quintero M, Steel CM, Zeuthen J (to be published) Deficiency of malic enzyme: A possible marker for malignancy in lymphoid cells Ann Hum Genet
Reedman B, Klein G (1973) Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 11:499
Rosén A, Clements G, Klein G, Zeuthen J (1977) Double Immunoglobulin production in cloned somatic cell hybrids between two human lymphoid lines. Cell 11:139
Rutherford TR, Clegg JB, Weatherall DJ (1979) K562 human leukaemic cells synthesize embryonic haemoglobin in response to haemin. Nature 280:164
Singer PA, Williamson AR (1979) A novel interaction involving a Polypeptide chain (P33) in covalent linkage with IgM on the surface of a Burkitt lymphoma cell line (Daudi). Eur J Immunol 9:224
Steel CM, Woodward MA, Davidson C, Philipson J, Arthur E (1977) Non-random chromosome gains in human lymphoblastoid cell lines. Nature 270:349
Steinitz M, Klein G (1975) Comparison between growth characteristics of an Epstein-Barr virus (EBV)-genome negative lymphoma line and its EBV-converted subline in vitro. Proc Natl Acad Sci USA 72:3518
Steinitz M, Klein G (1976) Epstein-Barr virus (EBV)-induced change in saturation density and serum dependence of established, EBV-negative lymphoma lines in vitro. Virology 70:570
Steinitz M, Klein G (1977) Further studies on the differences in serum dependence in EBV-negative lymphoma lines and their in vitro converted, virusgenome carrying sublines. Eur J Cancer 13:1269
Steinitz M, Klein G, Koskimies S, Mäkelä O (1977) EB virus-induced B-lymphocyte cell lines producing specific antibody. Nature 269:420
Steinitz M, Koskimies S, Klein G, Mäkelä O (1978) Establishment of specific antibody producing human cell lines by antigen preselection and EBV transformation. Curr Top Microbiol Immunol 81:156
Steinitz M, Seppälä I, Klein G, Koskimies S, Mäkelä O (1979) Immunobiology 156:41
Steinitz M, Izak G, Cohen S, Ehrenfeld M, Flechner J (to be published) Continuous production of rheumatoid factor by in vitro EBV-transformed lymphocytes. Nature
Tanaka A, Nonoyama M, Glaser R (1977) Transcription of latent Epstein-Barr virus genomes in human epithelial/Burkitt hybrid cells. Virology 82:63
Tjian R, Fey G, Graessmann A (1978) Biological activity of purified simian virus 40 T antigen proteins. Proc Natl Acad Sci USA 75:1279
Van den Berghe, H, Parloir C, Gosseye S, Englebienne V, Cornu G, Sokal G (1979) Variant translocation in Burkitt lymphoma Cancer Genet Cytogenet 1:9
Van Furth R, Gorter H, Nadkarni JS, Klein E, Clifford P (1972) Synthesis of Immunoglobulins by biopsied tissues and cell lines from Burkitt’s lymphoma. Immunology 22:847
Yefenof E, Klein G (1976) Difference in antibody induced redistribution of membrane IgM in EBV-genome free and EBV-positive human lymphoid cells. Exp Cell Res 99:175
Yefenof E, Klein G, Ben-Bassat H, Lundin L (1977) Differences in the ConA-induced redistribution and agglutination patterns of EBV genome-free and EBV-carrying human lymphoma lines. Exp Cell Res 108:185
Zech L, Haglund U, Nilsson K, Klein G (1976) Characteristic chromosomal abnormalities in biopsies and lymphoid cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer 17:47
Zeuthen J, Nilsson K (1976) Hybridization of a human myeloma permanent cell line with mouse cells. Cell Differ 4:355
Zeuthen J, Friedrich U, Rosén A, Klein E (1977) Structural abnormalities in chromosome 15 in cell lines with reduced expression of Beta-2 microglobulin. Immunogenetics 4:567
Zeuthen J, Klein G, Ber R, Masucci G, Bisballe S, Povey S, Terasaki P, Ralph P (to be published) Human lymphoma/lymphoma and lymphoma/leukemia hybrids. I. Isolation, characterization, cell surface and B-cell marker studies. J Natl Cancer Inst
Zur Hausen H, Bornkamm GW, Schmidt R, Hecker E (1979) Tumor initiators and promotors in the induction of Epstein-Barr virus. Proc Natl Acad Sci USA 76:782
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Zeuthen, J., Klein, G. (1981). Some Recent Trends in Studies of Human Lymphoid Cells: B-Cells, Epstein-Barr Virus, and Transformation. In: Neth, R., Gallo, R.C., Graf, T., Mannweiler, K., Winkler, K. (eds) Modern Trends in Human Leukemia IV. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 26. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67984-1_30
Download citation
DOI: https://doi.org/10.1007/978-3-642-67984-1_30
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-10622-7
Online ISBN: 978-3-642-67984-1
eBook Packages: Springer Book Archive